tiprankstipranks
Advertisement
Advertisement

HK:9966 Stock Latest News

Alphamab’s Anbenitamab Scores Phase III Win in HER2+ Breast Cancer
Company AnnouncementsAlphamab’s Anbenitamab Scores Phase III Win in HER2+ Breast Cancer
2d ago
9966
Alphamab Executives Lift Stakes as HER2 Oncology Pipeline Advances
PremiumCompany Announcements
Alphamab Executives Lift Stakes as HER2 Oncology Pipeline Advances
7d ago
9966
Alphamab Oncology Reports Promising Phase I Data for Bispecific ADC JSKN016 in HER2-Negative Breast Cancer
PremiumCompany Announcements
Alphamab Oncology Reports Promising Phase I Data for Bispecific ADC JSKN016 in HER2-Negative Breast Cancer
10d ago
9966
Alphamab’s Anbenitamab Delivers Superior Phase III Results in HER2-Positive Breast Cancer
PremiumCompany Announcements
Alphamab’s Anbenitamab Delivers Superior Phase III Results in HER2-Positive Breast Cancer
11d ago
9966
Alphamab Wins China Approval for First HER2 Bispecific Antibody in Gastric Cancer
PremiumCompany Announcements
Alphamab Wins China Approval for First HER2 Bispecific Antibody in Gastric Cancer
14d ago
9966
Alphamab Oncology Sets AGM to Seek Share Buyback and Issuance Mandates
PremiumCompany AnnouncementsAlphamab Oncology Sets AGM to Seek Share Buyback and Issuance Mandates
23d ago
9966
Alphamab Doses First Patient in Phase II Trial of JSKN033 for Advanced Cervical Cancer
Premium
Company Announcements
Alphamab Doses First Patient in Phase II Trial of JSKN033 for Advanced Cervical Cancer
1M ago
9966
Alphamab Oncology Grants 250,000 Restricted Award Shares to Key Employees
Premium
Company Announcements
Alphamab Oncology Grants 250,000 Restricted Award Shares to Key Employees
2M ago
9966
Alphamab Oncology Secures Waiver to Appoint Joint Company Secretary
PremiumCompany Announcements
Alphamab Oncology Secures Waiver to Appoint Joint Company Secretary
2M ago
9966
Alphamab’s KN026 Breast Cancer Trial Secures High-Profile ASCO 2026 Slot
PremiumCompany Announcements
Alphamab’s KN026 Breast Cancer Trial Secures High-Profile ASCO 2026 Slot
2M ago
9966
Alphamab Oncology Reshapes Company Secretariat, Seeks Listing Rules Waiver
PremiumCompany Announcements
Alphamab Oncology Reshapes Company Secretariat, Seeks Listing Rules Waiver
2M ago
9966
Alphamab’s KN026 Phase III Breast Cancer Trial Hits Key Efficacy Goal
PremiumCompany Announcements
Alphamab’s KN026 Phase III Breast Cancer Trial Hits Key Efficacy Goal
2M ago
9966
Alphamab Oncology Swings to Loss as R&D Spend Climbs but Cancer Pipeline Advances
PremiumCompany AnnouncementsAlphamab Oncology Swings to Loss as R&D Spend Climbs but Cancer Pipeline Advances
3M ago
9966
Alphamab Starts Phase III Trial of Next-Gen HER2 Drug in High-Risk Breast Cancer
Premium
Company Announcements
Alphamab Starts Phase III Trial of Next-Gen HER2 Drug in High-Risk Breast Cancer
3M ago
9966
Alphamab Advances JSKN016 Into Phase III for Hard-to-Treat Breast Cancer
Premium
Company Announcements
Alphamab Advances JSKN016 Into Phase III for Hard-to-Treat Breast Cancer
3M ago
9966
Alphamab Oncology Names New CFO as Capital Markets Vice President Resigns
PremiumCompany Announcements
Alphamab Oncology Names New CFO as Capital Markets Vice President Resigns
3M ago
9966
Alphamab Oncology Starts First-in-Human Trial of Novel Bispecific ADC JSKN027
PremiumCompany Announcements
Alphamab Oncology Starts First-in-Human Trial of Novel Bispecific ADC JSKN027
3M ago
9966
Alphamab Wins CDE Nod for First-in-Class Dual-Payload Cancer ADC JSKN021
PremiumCompany Announcements
Alphamab Wins CDE Nod for First-in-Class Dual-Payload Cancer ADC JSKN021
3M ago
9966
Alphamab Oncology Sets Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Alphamab Oncology Sets Board Meeting to Approve 2025 Annual Results
3M ago
9966
Alphamab Oncology Names Veteran Biologics Executive as Chief Technology Officer
PremiumCompany AnnouncementsAlphamab Oncology Names Veteran Biologics Executive as Chief Technology Officer
3M ago
9966
Alphamab Oncology’s KN035 NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
Premium
Company Announcements
Alphamab Oncology’s KN035 NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
5M ago
9966
Alphamab Wins CDE Acceptance for Phase II Trial of Novel Cervical Cancer Therapy JSKN033
Premium
Company Announcements
Alphamab Wins CDE Acceptance for Phase II Trial of Novel Cervical Cancer Therapy JSKN033
5M ago
9966

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >